Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population

Tools
- Tools
+ Tools

Mossong, Joël and Muller, C. P. . (2000) Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiology and Infection, Vol.124 (No.2). pp. 273-278. ISSN 0950-2688

[img]
Preview
PDF
WRAP_Mossong_estimation_measles.pdf - Draft Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Download (432Kb)
Official URL: http://dx.doi.org/10.1017/S0950268899003672

Abstract

From March to July 1996 a measles outbreak occurred in northern Luxembourg with 110 reported cases centered around two primary schools (85 cases) and the surrounding community (25 cases). Eighty four suspected cases were confirmed serologically. Vaccine coverage was estimated from questionnaire-based surveys at the two primary schools to be 70 and 76%, respectively. Vaccine efficacy during the outbreak was estimated to be 94.6% [95% confidence interval (CI) 90·4–97·0]. Using the information from the school surveys, we obtained estimates of the basic reproduction number of measles of 7·7 (95% CI 4·4–11·0) and 6·2 (95% CI 3·5–8·9), respectively. Assuming a 95% vaccine efficacy, these estimates correspond to minimal vaccine coverages of 91·6% (95% CI 81·4–95·7) and 88·3% (95% CI 75·5–93·4) which would have been necessary to minimize the chances of a major outbreak occurring. We can confirm that major outbreaks in similar school settings can only be prevented if vaccination coverage exceeds 90%.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH): Measles -- Epidemiology -- Luxembourg, Measles -- Vaccination -- Luxembourg, Virus diseases -- Transmission, Virus diseases -- Immunological aspects
Journal or Publication Title: Epidemiology and Infection
Publisher: Cambridge University Press
ISSN: 0950-2688
Date: 2000
Volume: Vol.124
Number: No.2
Page Range: pp. 273-278
Identification Number: 10.1017/S0950268899003672
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Luxembourg. Ministère de l'Education Nationale et de la Formation Professionnelle
Grant number: BFR 96/027 (MENFP)
References: 1. Division de la Médicine Préventive et Sociale. Enquète de couverture vaccinale au Grand-Duché de Luxembourg. Direction de la Santé, 1997. 2. Bouche FB, Brons NHC, Houard S, Schneider F, Muller CP. Evaluation of hemagglutinin proteinspecific immunoglobulin M for diagnosis of measles by an enzyme-linked immunosorbent assay based on recombinant protein produced in a high-efficiency mammalian expression system. J Clin Microbiol 1998; 36: 3509±13. 3. Ratnam S, Gadag V, West R, et al. Comparison of commercial enzyme-immunoassay kits with plaque reduction neutralization test for detection of measlesvirus antibody. J Clin Microbiol 1995; 33: 811±5. 4. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: A word-processing, database, and statistics program for public health on IBM-compatible microcomputers Atlanta, Georgia, USA: Centers for Disease Control and Prevention, 1995. 5. Anderson RM, May RM. Infectious diseases of humans. Oxford: Oxford University Press, 1991. 6. Becker NG. Analysis of infectious disease data. Chapman and Hall, 1989. 7. Hanses F, van Binnendijk R, Ammerlaan W, et al. Genetic variability of measles viruses circulating in the BENELUX. Arch Virol 1999; In Press. 8. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990; 9: 101±10. 9. Olive! JM. Measles immunization policies and control in Europe. Pediatr Pulmonol 1997; Suppl; 16: 284±5. 10. Helwig H, Mertsola J, Harvey D, Nicolopoulos D, Schaack JC, Sedlak W. Childhood immunisation in the European Union. Eur J Pediatr 1998; 157: 676±80. 11. Lévy-Bruhl D, Pebody R, Veldhuijzen I, Valenciano M, Osborne K. ESEN: A comparison of vaccination programmes ± part three: measles, mumps and rubella. Eurosurveillance 1998; 3: 115±9. 12. Guérin N, Roure C. Immunisation coverage in the European Union. Eurosurveillance 1997; 2: 2±4. 13. Becker NG, Hasofer NG. Estimating the transmission rate for a highly infectious disease. Biometrics 1998; 54: 730±8. 14. Lyons RA, Jones HI, Salmon RL. Successful control of a school based outbreak by immunization. Epidemiol Infect 1994; 113: 367±75. 15. Nigatu W, Nokes DJ, Enquselassie F, et al. Detection of measles specific IgG on oral fluid using an FITC} anti-FITC IgG capture enzyme linked immunosorbent assay. J Virol Methods 1999; 83: 135±44.
URI: http://wrap.warwick.ac.uk/id/eprint/847

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us